Publication:
Malignancy risk in systemic Lupus Erythematosus patients treated with cyclophosphamide

Simple item page
dc.contributor.authorsYilmaz, N.; Emmungil, H.; Gucenmez, S.; Ozen, G.; Yildiz, F.; Balkarli, A.; Kimyon, G.; Coskun, B. N.; Dogan, I.; Pamuk, O. N.; Yasar, S.; Cetin, G. Yildirim; Yazici, A.; Esmen, S. Ergulu; Cagatay, Y.; Yilmaz, S.; Celle, A.; Cefle, A.; Sayarhoglu, M.; Kasifoglu, T.; Karadag, O.; Pehlivan, Y.; Dalilic, E.; Kisacik, B.; Cobankara, V.; Erken, E.; Direskeneli, H.; Aksu, K.; Yavuz, S.
dc.date.accessioned2022-03-12T16:15:53Z
dc.date.accessioned2026-01-10T18:58:21Z
dc.date.available2022-03-12T16:15:53Z
dc.date.issued2015
dc.identifier.doidoiWOS:000360421900240
dc.identifier.eissn1593-098X
dc.identifier.issn0392-856X
dc.identifier.urihttps://hdl.handle.net/11424/225669
dc.identifier.wosWOS:000360421900240
dc.language.isoeng
dc.publisherCLINICAL & EXPER RHEUMATOLOGY
dc.relation.ispartofCLINICAL AND EXPERIMENTAL RHEUMATOLOGY
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.titleMalignancy risk in systemic Lupus Erythematosus patients treated with cyclophosphamide
dc.typeconferenceObject
dspace.entity.typePublication
oaire.citation.endPageS67
oaire.citation.issue3
oaire.citation.startPageS67
oaire.citation.titleCLINICAL AND EXPERIMENTAL RHEUMATOLOGY
oaire.citation.volume33

Files

Collections

Araştırma Çıktıları